Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

NALDEMEDINE vs NALMEFENE: Which Drug Is Safer?

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

NALDEMEDINE vs NALMEFENE: Safety Overview

Metric NALDEMEDINE NALMEFENE
Total FAERS Reports 677 197
Deaths Reported 167 77
Death Rate 24.7% 39.1%
Hospitalizations 105 118
Average Patient Age 66.5 yrs 44.2 yrs
% Female Patients 54.4% 39.3%
FDA Approval Date Mar 23, 2017 Apr 17, 1995
Manufacturer BioDelivery Sciences International Inc Purdue Pharma L.P.
Route ORAL INTRAMUSCULAR
Marketing Status Prescription Discontinued